TY - JOUR
T1 - Definitions of histocompatibility typing terms
T2 - Harmonization of Histocompatibility Typing Terms Working Group
AU - Nunes, Eduardo
AU - Heslop, Helen
AU - Fernandez-Vina, Marcelo
AU - Taves, Cynthia
AU - Wagenknecht, Dawn R.
AU - Eisenbrey, A. Bradley
AU - Fischer, Gottfried
AU - Poulton, Kay
AU - Wacker, Kara
AU - Hurley, Carolyn Katovich
AU - Noreen, Harriet
AU - Sacchi, Nicoletta
N1 - Funding Information:
These definitions have been reviewed by representatives from the organizations listed below. The extent to which each organization is able to incorporate the definitions above can be found on the Web site for each organization. AABB American Society for Blood and Marrow Transplantation (ASBMT) American Society for Histocompatibility and Immunogenetics (ASHI) College of American Pathologists (CAP) European Federation for Immunogenetics (EFI) Foundation for the Accreditation of Cellular Therapy (FACT) National Marrow Donor Program (NMDP) World Marrow Donor Association (WMDA)
PY - 2011/12
Y1 - 2011/12
N2 - Histocompatibility testing for stem cell and solid organ transplantation has become increasingly complex as newly discovered human leukocyte antigen (HLA) alleles are described. HLA typing assignments reported by laboratories are used by physicians and donor registries for matching donors and recipients. To communicate effectively, a common language for histocompatibility terms should be established. In early 2010, representatives from clinical, registry, and histocompatibility organizations joined together as the Harmonization of Histocompatibility Typing Terms Working Group to define a consensual language for laboratories, physicians and registries to communicate histocompatibility typing information. The Working Group defined terms for HLA typing resolution, HLA matching and a format for reporting HLA assignments. In addition, definitions of verification typing and extended typing were addressed. The original draft of the Definitions of Histocompatibility Typing Terms was disseminated to colleagues from each organization to gain feedback and create a collaborative document. Commentary gathered during this 90-day review period were discussed and implemented for preparation of this report. Histocompatibility testing continues to evolve thus, the definitions agreed upon today, likely will require refinement and perhaps additional terminology in the future.
AB - Histocompatibility testing for stem cell and solid organ transplantation has become increasingly complex as newly discovered human leukocyte antigen (HLA) alleles are described. HLA typing assignments reported by laboratories are used by physicians and donor registries for matching donors and recipients. To communicate effectively, a common language for histocompatibility terms should be established. In early 2010, representatives from clinical, registry, and histocompatibility organizations joined together as the Harmonization of Histocompatibility Typing Terms Working Group to define a consensual language for laboratories, physicians and registries to communicate histocompatibility typing information. The Working Group defined terms for HLA typing resolution, HLA matching and a format for reporting HLA assignments. In addition, definitions of verification typing and extended typing were addressed. The original draft of the Definitions of Histocompatibility Typing Terms was disseminated to colleagues from each organization to gain feedback and create a collaborative document. Commentary gathered during this 90-day review period were discussed and implemented for preparation of this report. Histocompatibility testing continues to evolve thus, the definitions agreed upon today, likely will require refinement and perhaps additional terminology in the future.
KW - Extended typing
KW - HLA matching
KW - HLA typing resolution
KW - Verification typing
UR - http://www.scopus.com/inward/record.url?scp=80053926838&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80053926838&partnerID=8YFLogxK
U2 - 10.1016/j.humimm.2011.06.002
DO - 10.1016/j.humimm.2011.06.002
M3 - Article
C2 - 21723898
AN - SCOPUS:80053926838
SN - 0198-8859
VL - 72
SP - 1214
EP - 1216
JO - Human Immunology
JF - Human Immunology
IS - 12
ER -